Complex view on biomedical activity of caffeine;Komplexný pohľad na biomedicínsky účinok kofeínu

Acta Facultatis Pharmaceuticae Universitatis Comenianae

Volumn 56, Issue , 2009, Pages 5-9

  Melnik M ^a   Kohutova M ^a  

^a Faculty of Natural Sciences   (Slovakia)

Author keywords

Biomedical activity; Caffeine

Indexed keywords

EID: 79956264276     PISSN: 03012298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. SADZUKA, Y., EGAWA, Y., SAWANISHI, H., MIYAMOTO, K., SONOBE, T: Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells. Toxicol. Lett. 135, 2002, p. 137-144.
2. VAN DEN BERG, H.W., FAVOL, H.N.A., ROBERTS, J.J.: Caffeine as inhibition of DNA repain. J. Clin. Hematol. Oncol. 7, 1977, p. 349-73.
3. FURUSAWA, S., MALKAWA, I., FUJIMURA, T., TAKAYANAGI, Y., SASAKI, K.: Influence of caffeine on effect of pirarubicin. Res. Commun. Subst. Abuse 14, 1993, p. 179.
4. ROBERTS, J.J.: Damage in DNA by cis-platin. Adv. Inorg. Biochem. 3, 1981, p. 273.
5. SHINOMIYA, N., SHINOMIYA, M., WAKIYAMA, H., KATSURA, Y., ROKUTANDA, M.: Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death. Exp. Cell Res. 210, 1994, p. 236-242.
6. TOMITA, K., TSUCHIYA, H: Cytotoxicity of cis-platin in the presence of caffeine. Clin. Ther. 11, 1989, p. 43-52.
7. TOMITA, K., TSUCHIYA, H.: Caffeine and anticancer drugs. Jpn. J. Cancer Res. 80, 1989, p. 83-88.
8. TRAGANOS, F., KAPUSCINSKI, J., GONG, J., ARDELT, B., DARZYNKIEWICZ, R.J., DARZYNKIEWICZ, Z.: Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells. Cancer Res. 53, 1993, p. 4613-4618.
9. SHOYAB, M.: Caffeine inhibits the binding of dimethylbenz(a)anthracene to murine epidermal cells DNA in culture. Arch. Biochem. Biophys. 196, 1979, p. 307-310.
10. TRAGANOS, B., KAMINSKA-EDDY, B., DARZYNKIEWICZ, Z.: Caffeine reverses the cytotoxic and cell kinetic effects of Novantrone (mitoxantrone). Cell Prolif. 24, 1991, p. 305-319.
11. TRAGANOS, F., KAPUSCINSKI, J., DARZYNKIEWICZ, Z.: Caffeine modulates the effects of DNA-intercalating drugs in vitro: A flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Cancer Res. 51, 1991, p. 3682-3689.
12. ROTHWELL, K.: Dose-related inhibition of chemical carcinogenesis in mouse skin by caffeine. Nature 252, 1974, p. 69-70.
13. BEAULAC-BAILLARGEON, L., DESROSIERS, C.: Caffeine and cigarette, high risk. Am. J. Obstet. Gynecol. 157, 1987, p. 1236-1240.
14. GAUDIN, D., YIELDING, K.L.: Cyclophosphoamide activity and caffeine. Proc. Soc. Expt. Biol. Med. 131, 1969, p. 1413-1416.
15. SADZUKA, Y., IWAZAKI, A., MIYAGISHIMA, Y., NOZAWA, Y., HIROTA, S.: Caffeine, biochemical modulator of adriamycin. J. Cancer Res. 86, 1995, p. 594-599.
16. SADZUKA, Y., MOCHIZUKI, E., TATINO, Y.: Caffeine and adriamycin, antitumor activity. Jpn J. Cancer Res. 84, 1993, p. 348-353.
17. SADZUKA, Y., MOCHIZUKI, E., TATINO, Y.: Mechanism of caffeine modulation of the antitumor activity of adriamycin. Toxicol. Lett. 75, 1995, p. 39-49.
18. TOMITA, K., TSUCHIYA, H., SASAKI, T.: The combinationof cis-platin, adriamycin and caffein and wide effect antitumor activity. Gan to Kagaku Rycho 16, 1989, p. 576-584.
19. RAINSKA-GIEZEK, T.: Paracetamol. Rocz. Pomor. Akad. Med. Szczecenie 41, 1995, p. 69-84.
20. EL-BASSIONY, S.F., ABO-HASHIM, N., SIRAG, S.M., EL-GHAZALY, A.: Influence of caffeine on paracetamol induced hepatotoxicity in rats. J. Environ. Sci. 10, 1995, p. 233-242.
21. IQBAL, N., AHMAD, B., JANBAZ, K.H., UL HASSAN GILANI, A., SARFEUAZ, K.: The effect of caffeine on the pharmacokinetics of acetaminophen in man. Biopharm. Drug Dispos. 16, 1995, p. 481-487.
22. NISHIJIMA, Y., IKEDA, T., TAKAMUTSU, M., KISO, Y., SHIBATA, H., FUSHIKI, T., MORITANI, T.: Influence of caffeine ingestion on autonomic nervous activity during endurance exercise in humans. Eur. J. Appl. Physiol. 87, 202, p. 475-480.
23. LEBERMAN, H.R., FINE, B.J., KOBRICK, J.L., JOHN, J.D.E.: Study of effects caffeine on central nervous system. AGARD Conf. Proc. 1993, p. 533.
24. WURTS, S.W., EDGAR, D.M.: Caffeine during sleep deprivation: Sleep tendency and dynamics of recovery sleep in rats. Pharmacol. Biochem. Behav. 65, 2000, p. 155-162.
25. ENGELS, H.J., WIRTH, J.C., CELIK, S., DORSEY, J.L.: Influence of caffeine on metabolic and cardiovascular functions during sustained light intensity cycling and at rest. Int. J. Sport Nutr. Exercise Metab. 9, 1999, p. 361-370.
26. JUDY SU, Y.: Pfluegers Arch. Eur. J. Physiol. 421, 1921, p. 1-6.
27. LIM, D.Y., LEE, J.H., SHIK, W.S., KIM, S.B., LEE, E.H., LEE B.J., KO, S.T.: Studies on secretion of catecholamine evoked by caffeine from the isolated perfused rat adrenal gland. Arch. Pharm. Res. 14, 1991, p. 55-67.
28. SARDAO, A.V., OLIVEIRA, J.P., MORENO, A.J.M.: Caffeine enhances the calcium--dependent cardiac mitochondrial permeability transition: Relevance for caffeine toxicity. Toxicol. Appl. Pharmacol. 179, 2002, p. 50-56.
29. ANDERSON, D.E., HICKEY, M.S.: Effects of caffeine on the metabolic and catecholamine responses to exercise in 5 and 28 degrees. Med. Sci. Sports Exerc. 26, 1994, p. 453-458.
30. KAGAWA, Y., MAYUMI, N., HIGASHIGAWA, S., KATSUDA, K., KAKITO, M., INAGAKI, S., OHSUGI, H., SUMIDA, K., SAKURAI, M., EDOBASHI, T.: Mie Med. J. 42, 1992, p. 203-207.
31. VALDES, M., SHAYE, R., JOSEPH, F., JR., NAKAMOTO, T.: The effects of caffeine on the maxillary composition in the newborn rat. Calcif. Tissue Int. 50, 1992, p. 165-168.
32. KRUK, B., CHMURA, J., KRZEMINSKI, K., ZIEMBA, A.W., NAZAR, K., PEKKARINEN, H., KACIUBA-USCILKO, H.: Influence of caffeine, cold and exercise on multiple choice reaction time. Psychopharmacology 157, 2001, p. 197-201.